GORDON KEVIN K sold $137K of PGNY
GORDON KEVIN K sold 5,500 shares of Progyny, Inc. (PGNY) at $24.99 ($0.14M total) on 2026-05-27.
How this was made
The 30-second read
Why it matters
The newest fact is the director’s open-market sale details (shares, price, total value, and post-transaction holdings).
Market read
This is a routine insider-sale datapoint with limited trading implications absent any accompanying corporate catalyst.
What to watch
Insider sales can be tax- or diversification-driven; without context on prior sales, option exercises, or compensation, signal strength is weak.
Background
The article is an SEC Form 4 insider transaction disclosure for Progyny, Inc. (PGNY).
Ticker impact
Progyny director Gordon Kevin K filed a Form 4 open-market sale of 5,500 shares at $24.9900 on 2026-05-27.
Likely limited near-term impact; treat as informational rather than a fundamental catalyst.
The filing is primary-source and time-stamped, but the transaction is an insider sale without accompanying company news, guidance, or enforcement action.
Market effects
No clear sector read-through from a single director sale without additional corporate developments.
None indicated.
None indicated.
Counterpoint
Absence of a 10b5-1 plan could be interpreted by some traders as less mechanical selling, but the article provides no reason for the sale.
Key entities
- issuerProgyny, Inc.
Company whose director insider sale was reported on Form 4.
- insiderGordon Kevin K
Director who sold 5,500 shares in an open-market transaction.
